← Patent-cliff monitor small molecule ACETADOTE ACETYLCYSTEINE
Loss of exclusivity April 2032 latest FDA-listed patent expiry
Company Cumberland → See this company's full patent-cliff portfolio Drug detail Brand name ACETADOTE Active ingredient ACETYLCYSTEINE Strength 6GM/30ML (200MG/ML) Dosage form INJECTABLE Route INTRAVENOUS Modality Small molecule FDA approval January 2004 Marketing status RX
Listed patents Patent Expires Type 8722738 April 2032 use U-1373 9327028 July 2031 use U-1839 8148356 May 2026 product
Regulatory exclusivity Code Expires D-196 November 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.